Transcripts AIM ImmunoTech Inc. London S.E.

Actions

Marché Fermé - London S.E. Autres places de cotation 17:10:43 07/04/2026			Varia. 5j.	Varia. 1 janv.
0,5315 ^USD	-98,60 %		+112,60 %	-53,13 %

24/06	Aim Immunotech souligne ses progrès cliniques et les étapes clés de son programme Ampligen contre le cancer du pancréas	CI
18/06	AIM ImmunoTech franchit une étape clinique majeure : le dernier patient a reçu sa première dose dans l'étude de phase 2 DURIPANC sur le cancer du pancréas métastatique	CI

04/06	Transcript : AIM ImmunoTech Inc. - Special Call
01/04/25	Transcript : AIM ImmunoTech Inc., Q4 2024 Earnings Call, Apr 01, 2025
15/11/24	Transcript : AIM ImmunoTech Inc., Q3 2024 Earnings Call, Nov 15, 2024
16/08/24	Transcript : AIM ImmunoTech Inc., Q2 2024 Earnings Call, Aug 16, 2024
05/06/24	Transcript : AIM ImmunoTech Inc. - Special Call
16/05/24	Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024
02/04/24	Transcript : AIM ImmunoTech Inc., Q4 2023 Earnings Call, Apr 02, 2024
20/03/24	Transcript : AIM ImmunoTech Inc. - Special Call
10/01/24	Transcript : AIM ImmunoTech Inc. - Pre Recorded Special Call
15/11/23	Transcript : AIM ImmunoTech Inc., Q3 2023 Earnings Call, Nov 15, 2023
15/08/23	Transcript : AIM ImmunoTech Inc., Q2 2023 Earnings Call, Aug 15, 2023
15/08/17	Transcript : Hemispherx Biopharma, Inc., Q2 2017 Earnings Call, Aug 15, 2017
07/04/17	Transcript : Hemispherx Biopharma, Inc., 2016 Earnings Call, Apr 07, 2017
15/11/16	Transcript : Hemispherx Biopharma, Inc., Q3 2016 Earnings Call, Nov 15, 2016
19/08/16	Transcript : Hemispherx Biopharma, Inc., Q2 2016 Earnings Call, Aug 19, 2016
17/05/16	Transcript : Hemispherx Biopharma, Inc., Q1 2016 Earnings Call, May 17, 2016
30/03/16	Transcript : Hemispherx Biopharma, Inc., 2015 Earnings Call, Mar 30, 2016
22/03/12	Transcript : Hemispherx Biopharma, Inc., 2011 Earnings Call, Mar 22, 2012